SALVATORE, GIULIANA
SALVATORE, GIULIANA
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles
2018 Torino, Enza; Auletta, Luigi; Vecchione, Donatella; Orlandella Francesca, Maria; Salvatore, Giuliana; Iaccino, Enrico; Fiorenza, Dario; Grimaldi Anna, Maria; Sandomenico, Annamaria; Albanese, Sandra; Sarnataro, Daniela; Gramanzini, Matteo; Palmieri, Camillo; Scala, Giuseppe; Quinto, Ileana; Netti Paolo, Antonio; Salvatore, Marco; Greco, Adelaide
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
2011 Salerno P; GarciaRostan G; Piccinin S; Bencivenga TC; Di Maro G; Doglioni C; Basolo F; Maestro R; Fusco A; Santoro M; Salvatore G.
Pros and cons of cellular studies in developing new drugs for thyroid cancers.
2008 Salvatore, G; Carlomagno, F; Santoro, M
Receptor tyrosine kinase inhibitors in thyroid cancer.
2008 Castellone MD; Carlomagno F; Salvatore G; Santoro M.
Presence of BRAF V600E in very early stages of Papillary Thyroid carcinoma.
2007 Ugolini C; Giannini R; Lupi C; Salvatore G; Piccoli P; Proietti A; Elisei R; Santoro M; Basolo F.
BAY 43-9006 inhibition of oncogenic RET mutants.
2006 Carlomagno, F; Anaganti, S; Guida, T; Salvatore, G; Troncone, G; Wilhelm, Sm; Santoro, M
BRAF is a therapeutic target in aggressive thyroid carcinoma.
2006 Salvatore G; De Falco V; Salerno P; Nappi TC; Pepe S; Troncone G; Carlomagno F; Melillo RM; Wilhelm SM; Santoro M.
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma
2006 Kerry J. Rhoden; Kristian Unger; Giuliana Salvatore; Yesim Yilmaz; Volodymyr Vovk;Gennaro Chiappetta; Mazin B. Qumsiyeh; Jay L. Rothstein; Alfredo Fusco; Massimo Santoro;Horst Zitzelsberger;Giovanni Tallini
Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma.
2005 Guida, T; Salvatore, G; Faviana, P; Giannini, R; Garciarostan, G; Provitera, L; Basolo, F; Fusco, A; Carlomagno, F; Santoro, M
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
2005 Guarino, V; Faviana, P; Salvatore, G; Castellone, Md; Cirafici, Am; De Falco, V; Celetti, A; Giannini, R; Basolo, F; Melillo, Rm; Santoro, M
Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.
2004 Salvatore, G; Giannini, R; Faviana, P; Caleo, A; Migliaccio, I; Fagin, Ja; Nikiforov, Ye; Troncone, G; Palombini, L; Basolo, F; Santoro, M
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
2004 Lima, J; Trovisco, V; Soares, P; Máximo, V; Magalhães, J; Salvatore, G; Santoro, M; Bogdanova, T; Tronko, M; Abrosimov, A; Jeremiah, S; Thomas, G; Williams, D; Sobrinhosimões, M
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.
2004 Unger K; Zitzelsberger H; Salvatore G; Santoro M; Bogdanova T; Braselmann H; Kastner P; Zurnadzhy L; Tronko N; Hutzler P; Thomas G.
Induction of caspase-dependent programmewd cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins.
2004 Decker T; Oelsner M; Kreitman RJ; Salvatore G; Wang QC; Pastan I; Peschel C; Licht T.
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
2004 Nikiforova MN; Ciampi R; Salvatore G; Santoro M; Gandhi M; Knauf JA; Thomas GA; Jeremiah S; Bogdanova TI; Tronko MD; Fagin JA; Nikiforov YE.
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
2003 Nikiforova, Mn; Kimura, Et; Gandhi, M; Biddinger, Pw; Knauf, Ja; Basolo, F; Zhu, Z; Giannini, R; Salvatore, G; Fusco, A; Santoro, M; Fagin, Ja; Nikiforov, Ye
DNA Immunization follone by a single boost with cells: a protein-freeimmunization protocol for production of monoclonal antibodies against the native form of membrane proteins.
2003 Nagata, S; Salvatore, G; Pastan, I
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase.
2002 Salvatore G. ; Nagata S. ; Billaud M. ; Santoro M. ; Vecchio G. ; Pastan I.
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1).
2002 Baldassarre G. ; Bruni P. ; Boccia A. ; Salvatore G. ; Melillo R.M. ; Motti M.L. ; Napolitano M. ; Belletti B. ; Fusco A. ; Santoro M. ; Viglietto G.
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.
2002 Basolo, F; Giannini, R; Monaco, C; Melillo, Rm; Carlomagno, F; Pancrazi, M; Salvatore, G; Chiappetta, G; Pacini, F; Elisei, R; Miccoli, P; Pinchera, A; Fusco, A; Santoro, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles | 1-gen-2018 | Torino, Enza; Auletta, Luigi; Vecchione, Donatella; Orlandella Francesca, Maria; Salvatore, Giuliana; Iaccino, Enrico; Fiorenza, Dario; Grimaldi Anna, Maria; Sandomenico, Annamaria; Albanese, Sandra; Sarnataro, Daniela; Gramanzini, Matteo; Palmieri, Camillo; Scala, Giuseppe; Quinto, Ileana; Netti Paolo, Antonio; Salvatore, Marco; Greco, Adelaide | |
| TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype. | 1-gen-2011 | Salerno P; GarciaRostan G; Piccinin S; Bencivenga TC; Di Maro G; Doglioni C; Basolo F; Maestro R; Fusco A; Santoro M; Salvatore G. | |
| Pros and cons of cellular studies in developing new drugs for thyroid cancers. | 1-gen-2008 | Salvatore, G; Carlomagno, F; Santoro, M | |
| Receptor tyrosine kinase inhibitors in thyroid cancer. | 1-gen-2008 | Castellone MD; Carlomagno F; Salvatore G; Santoro M. | |
| Presence of BRAF V600E in very early stages of Papillary Thyroid carcinoma. | 1-gen-2007 | Ugolini C; Giannini R; Lupi C; Salvatore G; Piccoli P; Proietti A; Elisei R; Santoro M; Basolo F. | |
| BAY 43-9006 inhibition of oncogenic RET mutants. | 1-gen-2006 | Carlomagno, F; Anaganti, S; Guida, T; Salvatore, G; Troncone, G; Wilhelm, Sm; Santoro, M | |
| BRAF is a therapeutic target in aggressive thyroid carcinoma. | 1-gen-2006 | Salvatore G; De Falco V; Salerno P; Nappi TC; Pepe S; Troncone G; Carlomagno F; Melillo RM; Wilhelm SM; Santoro M. | |
| RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma | 1-gen-2006 | Kerry J. Rhoden; Kristian Unger; Giuliana Salvatore; Yesim Yilmaz; Volodymyr Vovk;Gennaro Chiappetta; Mazin B. Qumsiyeh; Jay L. Rothstein; Alfredo Fusco; Massimo Santoro;Horst Zitzelsberger;Giovanni Tallini | |
| Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma. | 1-gen-2005 | Guida, T; Salvatore, G; Faviana, P; Giannini, R; Garciarostan, G; Provitera, L; Basolo, F; Fusco, A; Carlomagno, F; Santoro, M | |
| Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. | 1-gen-2005 | Guarino, V; Faviana, P; Salvatore, G; Castellone, Md; Cirafici, Am; De Falco, V; Celetti, A; Giannini, R; Basolo, F; Melillo, Rm; Santoro, M | |
| Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. | 1-gen-2004 | Salvatore, G; Giannini, R; Faviana, P; Caleo, A; Migliaccio, I; Fagin, Ja; Nikiforov, Ye; Troncone, G; Palombini, L; Basolo, F; Santoro, M | |
| BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. | 1-gen-2004 | Lima, J; Trovisco, V; Soares, P; Máximo, V; Magalhães, J; Salvatore, G; Santoro, M; Bogdanova, T; Tronko, M; Abrosimov, A; Jeremiah, S; Thomas, G; Williams, D; Sobrinhosimões, M | |
| Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. | 1-gen-2004 | Unger K; Zitzelsberger H; Salvatore G; Santoro M; Bogdanova T; Braselmann H; Kastner P; Zurnadzhy L; Tronko N; Hutzler P; Thomas G. | |
| Induction of caspase-dependent programmewd cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. | 1-gen-2004 | Decker T; Oelsner M; Kreitman RJ; Salvatore G; Wang QC; Pastan I; Peschel C; Licht T. | |
| Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. | 1-gen-2004 | Nikiforova MN; Ciampi R; Salvatore G; Santoro M; Gandhi M; Knauf JA; Thomas GA; Jeremiah S; Bogdanova TI; Tronko MD; Fagin JA; Nikiforov YE. | |
| BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. | 1-gen-2003 | Nikiforova, Mn; Kimura, Et; Gandhi, M; Biddinger, Pw; Knauf, Ja; Basolo, F; Zhu, Z; Giannini, R; Salvatore, G; Fusco, A; Santoro, M; Fagin, Ja; Nikiforov, Ye | |
| DNA Immunization follone by a single boost with cells: a protein-freeimmunization protocol for production of monoclonal antibodies against the native form of membrane proteins. | 1-gen-2003 | Nagata, S; Salvatore, G; Pastan, I | |
| Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase. | 1-gen-2002 | Salvatore G. ; Nagata S. ; Billaud M. ; Santoro M. ; Vecchio G. ; Pastan I. | |
| Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). | 1-gen-2002 | Baldassarre G. ; Bruni P. ; Boccia A. ; Salvatore G. ; Melillo R.M. ; Motti M.L. ; Napolitano M. ; Belletti B. ; Fusco A. ; Santoro M. ; Viglietto G. | |
| Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. | 1-gen-2002 | Basolo, F; Giannini, R; Monaco, C; Melillo, Rm; Carlomagno, F; Pancrazi, M; Salvatore, G; Chiappetta, G; Pacini, F; Elisei, R; Miccoli, P; Pinchera, A; Fusco, A; Santoro, M |